πŸ‡ΊπŸ‡Έ FDA
Patent

US 11866476

Masked IL-2-Fc fusion polypeptides

granted A61KA61K38/00A61P

Quick answer

US patent 11866476 (Masked IL-2-Fc fusion polypeptides) held by Xilio Development, Inc. expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xilio Development, Inc.
Grant date
Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61P, A61P35/00